# Timing of VTE Prophylaxis in TBI

> **NCT03081169** · PHASE4 · WITHDRAWN · sponsor: **Loyola University**

## Conditions studied

- TBI (Traumatic Brain Injury)
- VTE (Venous Thromboembolism)

## Interventions

- **DRUG:** Enoxaparin Sodium 150 MG/ML Prefilled Syringe
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT03081169
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04-03
- **Primary completion:** 2019-08-12
- **Final completion:** 2019-08-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Recruitment not started due to potential conflicting study at same institution. May renew study in the future.
- **Last updated:** 2019-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081169, "Timing of VTE Prophylaxis in TBI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03081169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*